N (%)

Median (Range)

Follow-Up of the Surviving Patients (months)

30.4 (2.5 - 81.2)

Follow-Up for All Patients (months)

18 (1.2 - 81.2)

Age (years)

70.5 (41.7 - 91.1)

Prescription Dose (Gy)

62 (43.1 - 74.0)

1.8

Mean Lung Dose (Gy)

13.6 (4.4 - 22.4)

Lung V20 (%)

23.9 (5.7 - 41.5)

Tumor Volume [cc] (CTV)

118.5 (1.1 - 706)

Technique 3D-CRT

49 (41.2%)

IMRT

70 (58.8%)

Stage IIIA

72 (60.5%)

IIIB

47 (39.5%)

Chemo Yes

106 (89.1%)

No

13 (10.9%)

Laterality Left

44 (37%)

Right

74 (62.2%)

Undefined

1 (0.8%)

Site Lower Lobe

26 (21.8%)

Middle Lobe

5 (4.2%)

Upper Lobe

80 (67.2%)

Bronchus

5 (4.2%)

Undefined

3 (2.5%)

Alive at Last Follow-up

47 (39.5%)

Deceased at Last Follow-Up

72 (60.5%)